For all of the groundbreaking advancements in cancer treatment over the last decades, the first step for tackling almost all solid tumors is still surgery. If the cancer comes back, medicines like ...

Relation Insurance Services, which is backed by Aquiline Capital Partners, has acquired PT Business Solutions, a South Pasadena, California-based provider of employee benefit, HR, payroll, workers’ ...

The combination of intismeran autogene and Keytruda reduced recurrence or death risk by 49% in high-risk melanoma patients over five years. The study involved 157 patients with stage 3/4 melanoma who ...

Meta has now rolled out the "Build Your 2026 Algorithm" feature for Instagram Reels to allow users use it to personalize their feeds. Instagram Reels 'Build Your 2026 Algorithm' Now Live After a test ...

LinkedIn's algorithm has changed, making old tactics obsolete. Align your profile with content topics. Prioritize "saves" as the key engagement metric by creating valuable, referenceable content. Post ...

X may soon provide more insight into how its algorithm works. On Saturday, Elon Musk posted on the platform to say that the company "will make the new X algorithm, including all code used to determine ...

Social media platform X will open its new algorithm to the public in seven days, Elon Musk said on Saturday, including the code used to decide what posts and advertisements are recommended to users.

Elon Musk's social media platform X will make its algorithm open source in seven days, the billionaire businessman said on Saturday, including the code that governs what posts are recommended to users ...

Please provide your email address to receive an email when new articles are posted on . A novel AI multimodal model outperformed Oncotype DX in overall distant recurrence rate at 15 years. Additional ...

LONDON, Dec 10 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared with standard endocrine ...

In a population-based cohort of 15- to 39-year-olds diagnosed with cancer, the risk for metastatic recurrence varied widely by cancer type and stage, and survival after recurrence was worse than after ...